Vigabatrin vs placebo
Ataxia · people (aged 10–64 years) with drug‐resistant focal epilepsy
It is very uncertain whether vigabatrin changes adverse effects: ataxia Duration of treatment (range): 7–36 weeks compared with placebo (very low certainty).
1 finding from 1 review
- RR 2.76 [0.96, 7.94]7 studies · 481 participantsVery low